People

Ward Capoen

Ward Capoen

Ward Capoen serves as Board member at Sibylla Biotech. A V-Bio investor who joined in2016 after molecular-biology research and biotechnology investment analysis at Candriam. Holds Ghent biotechnology doctorate and Vlerick MBA.

Roles

Sibylla Biotech

Board member

Current
Current
Augustine Therapeutics

Interim Management (2019 company launch; historical)

Current